Dr. Michael Möller is co-founder of the Company and co-inventor of the technologies; he is an organic research chemist with extensive international experience gathered at Philips University, Marburg, Germany, Okayama University of Science, Japan, Stanford University, USA and the IBM Almaden Research Center, USA; Michael’s expertise in designing, characterizing and synthesizing novel molecules both with specific material applications and for assimilation into useful nanostructures led him to join the School of Pharmacy of the University of Geneva where pioneering work on novel molecules and structures as drug delivery mechanisms has been made. The combination of expertise in chemistry, synthesis and practical application in drug delivery has enabled the establishment of key intellectual property leading directly to the formation of Apidel.